US drug firm offers cure for blindness at $425,000 an eye

Spark Therapeutics says responsible price for Luxturna gene therapy ensures access for patients with retinal defect A drug whose inventors claim it can cure a rare form of blindness is to be one of the most expensive medicines ever sold at $850,000 (630,000). Luxturna is injected directly into the eye to address the root cause of visual impairment by replacing a defective gene in the retina. It is the first gene therapy to be approved for use in the US, and was given the go-ahead by the Federal Drug Administration…

Read More